Hieke K - Search Results

1

Economic analysis of adjuvant therapy with interferon alpha-2a in stage II malignant melanoma.

Lafuma A, Dreno B, Delaunay M, Emery C, Fagnani F, Hieke K, Bonerandi JJ, Grob JJ; French Cooperative Group on Melanoma. Lafuma A, et al. Among authors: hieke k. Eur J Cancer. 2001 Feb;37(3):369-75. doi: 10.1016/s0959-8049(00)00411-1. Eur J Cancer. 2001. PMID: 11239759

2

Evaluation of non-medical costs associated with visual impairment in four European countries: France, Italy, Germany and the UK.

Lafuma A, Brézin A, Lopatriello S, Hieke K, Hutchinson J, Mimaud V, Berdeaux G. Lafuma A, et al. Among authors: hieke k. Pharmacoeconomics. 2006;24(2):193-205. doi: 10.2165/00019053-200624020-00007. Pharmacoeconomics. 2006. PMID: 16460138

3

Epidemiology, medical outcomes and costs of catheter-related bloodstream infections in intensive care units of four European countries: literature- and registry-based estimates.

Tacconelli E, Smith G, Hieke K, Lafuma A, Bastide P. Tacconelli E, et al. Among authors: hieke k. J Hosp Infect. 2009 Jun;72(2):97-103. doi: 10.1016/j.jhin.2008.12.012. Epub 2009 Feb 25. J Hosp Infect. 2009. PMID: 19246122 Review.

4

Capecitabine (Xeloda) improves medical resource use compared with 5-fluorouracil plus leucovorin in a phase III trial conducted in patients with advanced colorectal carcinoma.

Twelves C, Boyer M, Findlay M, Cassidy J, Weitzel C, Barker C, Osterwalder B, Jamieson C, Hieke K; Xeloda Colorectal Cancer Study Group. Twelves C, et al. Among authors: hieke k. Eur J Cancer. 2001 Mar;37(5):597-604. doi: 10.1016/s0959-8049(00)00444-5. Eur J Cancer. 2001. PMID: 11290435 Clinical Trial.

5

Association between visual acuity and medical and non-medical costs in patients with wet age-related macular degeneration in France, Germany and Italy.

Bandello F, Augustin A, Sahel JA, Benhaddi H, Negrini C, Hieke K, Berdeaux GH; MICMAC (MICro-economics of MACular degeneration) Study Group. Bandello F, et al. Among authors: hieke k. Drugs Aging. 2008;25(3):255-68. doi: 10.2165/00002512-200825030-00007. Drugs Aging. 2008. PMID: 18331076

6

Anxiety and depression prevalence rates in age-related macular degeneration.

Augustin A, Sahel JA, Bandello F, Dardennes R, Maurel F, Negrini C, Hieke K, Berdeaux G. Augustin A, et al. Among authors: hieke k. Invest Ophthalmol Vis Sci. 2007 Apr;48(4):1498-503. doi: 10.1167/iovs.06-0761. Invest Ophthalmol Vis Sci. 2007. PMID: 17389477

7

Costs of drug delivery for CHOP, COP/CVP, and fludarabine: an international assessment.

Herold M, Hieke K. Herold M, et al. Among authors: hieke k. Value Health. 2003 Mar-Apr;6(2):167-74. doi: 10.1046/j.1524-4733.2003.00227.x. Value Health. 2003. PMID: 12641867 Free article.

8

Health economic analysis of fluoropyrimidine-based therapies of colorectal cancer from the perspective of statutory sickness funds.

Grothey A, Kleeberg UR, Stauch M, Hieke K. Grothey A, et al. Among authors: hieke k. Z Gastroenterol. 2005 Feb;43(2):155-61. doi: 10.1055/s-2004-813708. Z Gastroenterol. 2005. PMID: 15700205

9

Costs of treatment of colorectal cancer in different settings in Germany.

Hieke K, Kleeberg UR, Stauch M, Grothey A. Hieke K, et al. Eur J Health Econ. 2004 Oct;5(3):270-3. doi: 10.1007/s10198-003-0220-3. Eur J Health Econ. 2004. PMID: 15714348

10

Cost-minimization analysis of CHOP, fludarabine and rituximab for the treatment of relapsed indolent B-cell non-Hodgkin's lymphoma in the U.K.

Sweetenham J, Hieke K, Kerrigan M, Howard P, Smartt PF, McIntyre AM, Townshend S. Sweetenham J, et al. Among authors: hieke k. Br J Haematol. 1999 Jul;106(1):47-54. doi: 10.1046/j.1365-2141.1999.01515.x. Br J Haematol. 1999. PMID: 10444162 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

18 results

Search Page

Filters